Literature DB >> 11673343

Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension.

P Verdecchia1, C Porcellati, G Reboldi, R Gattobigio, C Borgioni, T A Pearson, G Ambrosio.   

Abstract

BACKGROUND: It is uncertain whether left ventricular hypertrophy (LVH) confers an increased risk for cerebrovascular disease in apparently healthy patients with essential hypertension. METHODS AND
RESULTS: A total of 2363 initially untreated hypertensive patients (mean age 51+/-12 years, 47% women) free of previous cardiovascular disease were followed up for up to 14 years (mean 5 years). At entry, all patients underwent diagnostic tests, including ECG, echocardiography, and 24-hour ambulatory blood pressure (BP) monitoring. At entry, the prevalence of LVH was 17.6% by ECG (Perugia score) and 23.7% by echocardiography (LVM >125 g/m(2)). Over the subsequent years, 105 patients experienced a first stroke or transient ischemic attack. The cerebrovascular event rate was higher among patients with LVH at entry, diagnosed by either ECG or echocardiography, than among those without hypertrophy (both P<0.01). After control for the significant influence of age, sex, diabetes, and 24-hour mean ambulatory BP, LVH by ECG conferred an increased risk for cerebrovascular events (relative risk [RR] 1.79; 95% CI 1.17 to 2.76). LVH by echocardiography also conferred a higher risk for cerebrovascular events (RR 1.64; 95% CI 1.07 to 2.68). For each increase in LV mass of 1 SD (29 g/m(2)), there was a significant independent increase in the risk for cerebrovascular events (RR 1.31; 95% CI 1.09 to 1.58).
CONCLUSIONS: In apparently healthy patients with essential hypertension, LVH diagnosed by ECG or echocardiography confers an excess risk for stroke and transient ischemic attack independently of BP and other individual risk factors.

Entities:  

Mesh:

Year:  2001        PMID: 11673343     DOI: 10.1161/hc4201.097944

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  70 in total

1.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

2.  Mineralocorticoid-receptor blockade in hypertensive patients during angiotensin-converting enzyme inhibition: effects on left ventricular mass.

Authors:  Robert M Carey; Alexander G Logan
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

Review 3.  Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.

Authors:  Toru Kubo; Hiroaki Kitaoka
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

4.  Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions.

Authors:  Mark A Munger
Journal:  P T       Date:  2011-01

Review 5.  Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study.

Authors:  Cesare Cuspidi; Carla Sala; Anna Casati; Michele Bombelli; Guido Grassi; Giuseppe Mancia
Journal:  Hypertens Res       Date:  2016-11-17       Impact factor: 3.872

6.  Newly proposed electrocardiographic criteria for the diagnosis of left ventricular hypertrophy in a Chinese population.

Authors:  Qingmiao Shao; Lei Meng; Gary Tse; Abhishek C Sawant; Calista Zhuo Yi Chan; George Bazoukis; Adrian Baranchuk; Guangping Li; Tong Liu
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-10-03       Impact factor: 1.468

7.  Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly.

Authors:  Wesley T O'Neal; Mohamed F Almahmoud; Waqas T Qureshi; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-07-04       Impact factor: 2.136

Review 8.  The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Authors:  G Neil Thomas; Paul Chan; Brian Tomlinson
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

9.  Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.

Authors:  Manuel A Gómez-Marcos; José I Recio-Rodríguez; Emiliano Rodríguez-Sánchez; Yolanda Castaño-Sánchez; Angela de Cabo-Laso; Benigna Sánchez-Salgado; Carmela Rodríguez-Martín; Carmen Castaño-Sánchez; Leticia Gómez-Sánchez; Luis García-Ortiz
Journal:  BMC Public Health       Date:  2010-03-18       Impact factor: 3.295

10.  Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress.

Authors:  Thomas F Walsh; Erica Dall'Armellina; Haroon Chughtai; Timothy M Morgan; William Ntim; Kerry M Link; Craig A Hamilton; Dalane W Kitzman; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2009-08-03       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.